Clinical Trials Logo
  1. Home
  2. Human Papillomavirus Vaccines
  3. NCT03431246

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Human Papillomavirus Vaccines Clinical Trial

Official title:
Persistance of Anti-HPV After a Single Dose of Gardasil and the Effect of a Dose of Gardasil-9 When Administered 3-8 Years Later

Clinical Trial Summary

This study will assess the immunogenicity of one dose of Gardasil and one dose of Gardasil-9

Clinical Trial Description

This is a one group exploratory study.

The main objective of this study is to assess the persistance of anti-HPV after a single dose Gardasil and the effect of one dose of Gardasil-9 when administered 3-8 years later. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03431246
Study type Interventional
Source Laval University
Contact
Status Completed
Phase Phase 3
Start date October 1, 2016
Completion date December 5, 2016
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04587167 - HPV Vaccine Communication ECHO for Primary Care Clinics N/A
Completed NCT04180462 - Increasing Optimal Use of HPV Vaccination in Primary Care N/A
Recruiting NCT05932563 - Study on the Epidemiological Characteristics of Female HPV Vaccination in China
Completed NCT06345885 - Immunogenicity and Safety of One Dose of HPV Vaccine Phase 4
Not yet recruiting NCT06002282 - HPV Vaccine Confident Families N/A
Terminated NCT02535845 - Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial N/A
Recruiting NCT05932576 - A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women
Completed NCT02358083 - Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents N/A
Completed NCT02537756 - Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination N/A
Completed NCT04072159 - Community Pharmacists Vaccinate Against Cancer N/A